Source: Annual Congress 2009 - Epidemiology and management of lung cancer

Abstract

Methods
The National Lung Cancer Audit aims to record lung cancer outcomes on a large scale and through case-mix adjustment, start to explain variations in process seen across the UK. Although Wales and Scotland have submitted data, this abstract presents results for England only focussing on case-mix adjusted outcome data for patients first seen in 2007.
Results
By the end of June 2008, there were over 50,000 records on patients first seen in 2005-2007. In 2007, there were 22,066 patients representing approximately 75% of the expected number of cases. There have been improvements in markers of process and outcomes:

To correct for differences in case-mix, regression models were fitted to the data to compare organisations. Adjustments were made for sex, age, stage, performance status and deprivation. Figure 1 shows odds ratios for anti-cancer treatment and hazard ratios for median survival in NSCLC compared to a baseline organisation.

Conclusions
There remains a wide variation in care between organisations which is not completely explained by differences in case-mix, although not all possible factors could be adjusted for in these models due to lack of data (e.g. co-morbidities).

Rating:

Share or cite this content

Citations should be made in the following way:
P. Beckett, I. Woolhouse, R. Stanley, M. Peake (London, Leeds, United Kingdom). Case-mix adjusted outcomes in the national lung cancer audit in England. Eur Respir J 2009; 34: Suppl. 53, 4684

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 External comparison of hospitals concerning quality of oncological care of patients with lung cancer in an outcome evaluation study from a population-based regional cancer registry Source: Eur Respir J 2001; 18: Suppl. 33, 438s Year: 2001 Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001 Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey Source: Eur Respir J, 51 (5) 1702405; 10.1183/13993003.02405-2017 Year: 2018 An eleven year analysis of a national heath insurance database on primary lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Lung cancer incidence trends in Croatia: emergency for public health interventions Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Developing datasets for a national audit of hospital asthma care and organisation in England and Wales. Source: International Congress 2018 – Asthma and drugs Year: 2018 Chemotherapy for lung cancer in Scotland: a national survey Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002 Impact of a lung cancer screening programme on a London hospital service Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 The influence of the UK national lung cancer campaign on fast-track referrals to secondary care Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 An audit on the use of FDG-PET in the diagnosis and management of lung cancer in a district general hospital in the West Midlands, U.K. Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Health care expenditures of lung cancer: a Turkish experience Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018 Quality evaluation of primary care referrals to lung cancer services and their response in South London: Clinical practice in a pragmatic setting. Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 End-of-life care in oxygen-dependent COPD and cancer: a national population-based study Source: Eur Respir J 2015; 46: 1190-1193 Year: 2015 The European initiative for quality management in lung cancer care Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines Year: 2014 The European initiative for quality management in lung cancer care Source: Guideline 2014 Year: 2014 The European initiative for quality management in lung cancer care Source: Eur Respir J 2014; 43: 1254-1277 Year: 2014